Ophthalmic-Neurology Associates
7 Rue Morgan
Lille, France

Consultant's Note Prepared by Charles Moliere, M. D., FFCONP

Patient Information Name:
Beverly Gilbert ID: 152437A
DOB: 2127
Superficial Age: 15.
Place of birth: Home birth, Lille, France
Guardian: Claude Gilbert

To Dr. Boujedid,
Clinique de Lille 17
Avril, 2142

Dear Dr. Boujedid:

Thank you for the opportunity to review this fascinating case. Beverly Gilbert is a well-nourished and attractive fifteen-year-old pubescent African American female whose preliminary genome typing suggests a German-American ancestry.

Miss Gilbert is being sustained in cryostasis at La Clinique de Lille in a Cybertronics TM Holding Tank, Model Number 5412.

The child has been in a comatose state since her admission with a diagnosis of end-stage pediatric ALS Type IV. Ophthalmic-Neurology Associates was called in for a consultation when symptoms of iritis (inflamed corneas and purulent exudate) proved unresponsive to traditional therapy.

I have reviewed the chart and all previous consultations prior to examining the patient. History reveals acute endogenous uveitis of a puzzling and unknown etiology.

Inflammation of the uveal tract is observed in approximately forty percent of patients immersed in Cryostasis units, with full resolution in the majority of these cases. Attending physicians at La Clinique de Lille prescribed Cortico-Optho agents and Gantrymyc X11, and other targeted medications without success.

On examination, I observed an atypical Uveitis that shows no involvement of the retina or optic nerve. Sclerae are clear; no evidence presents showing Fuchs' heterochromic cyclitis, unilateral uveitis, raised intraocular pressure, iris nodules or iris atrophy. The pupils respond unevenly and erratically to light, painful, and aural stimulation.

I was unable to accurately measure full evoked potential and reliable brain wave patterns. Functional readings suggest that neural blocking agents or a functional neural barrier have been introduced that prevents external stimuli from reaching targeted areas. A case recently reported in the Journal of Cyberneurology reported a rise in the illicit use of Diopheolurotopicin and Meioconductin (commonly referred to by the street name of "Scramblers"). I detected trace elements of both agents in the toxicology scan. I am now suspicious that the initial diagnosis of pediatric ALS Type IV may be in error, as this patient does not respond as would be expected.

While vital signs and recorded volume and serologic functions indicate the patient is stable and performing well in the Cryo-Matrix regime, my concern is with the presumed interruption or barrier blocking neural pathways.

This interruption or barrier effectively prevents adequate thought infusion, memory updates, and DBS therapy; in other words, the patient is not benefiting from treatment. I am unable to determine the causative agents without further invasive investigation, which I shall attempt, pending the approval of the patient's guardian.

Differential Diagnosis:

• Atypical Cryogenic Iritis, etiology unknown.
• Irregular Cryostatic Cognitive Patterns suggesting a blockage or interference with Neurological pathways.
• Rule out Pediatric ALS, Type IV

Recommendations:

• Obtain Evoked Potential Neurological Testing and compare responses against baseline readings.
• Nucleonic Image Brain Scan and competency testing to determine mental facility
• Aggressive treatment of Iritis to begin immediately.
• Further toxicology and screening examinations.

Please do not hesitate to call upon me for clarification or further examination.

SIGNED:

DATED:

Charles Moliere, M.D. 17 Avril, 2142